Zhejiang Supcon Technology Co. Ltd. A

SUPCON Technology announced that on September 29, the company held the 23rd meeting of its sixth board of directors, where it reviewed and approved a proposal to adjust the upper limit of the share buyback price, raising it from no more than 68.53 yuan per share to no more than 133.50 yuan per share, nearly doubling the cap, with all other terms of the buyback plan unchanged. The company said the adjustment was made because the stock price had continued to exceed the buyback price cap, based on confidence in the company's future sustained and stable development and recognition of its value, as well as to ensure the smooth implementation of the buyback plan. The buyback plan began on October 24, 2025, with an original price cap of no more than 68.81 yuan per share and total buyback funds of no less than 500 million yuan and no more than 1 billion yuan. The repurchased shares were intended for equity incentives and employee stock ownership plans. Due to the implementation of the 2025 annual equity distribution, the buyback price cap was adjusted on June 8, 2026, to no more than 68.53 yuan per share. As of April 30, 2026, the company had repurchased approximately 6.3573 million shares through centralized bidding, accounting for 0.8035 percent of total share capital, with the highest repurchase price at 64.18 yuan per share and the lowest at 48.30 yuan per share. As of August 31, the cumulative number of repurchased shares remained approximately 6.3573 million. Since October 24, 2025, SUPCON Technology's share price has risen 48.58 percent, closing at 78.48 yuan on September 29, with a market capitalization of 62.09 billion yuan.

HEC Pharm's controlling shareholder, Shenzhen HEC Industrial, has proposed that the company use its own or self-raised funds to repurchase A-shares, with the buyback amount set at no less than 600 million yuan and no more than 1.2 billion yuan. The repurchase price will not exceed 150% of the average trading price of the stock over the 30 trading days prior to the board resolution, and the implementation period is within six months after board approval. In an after-hours announcement the same day, Shandong Gold Mining's chairman Wang Chenglong proposed a buyback of 300 million to 400 million yuan worth of A-shares, all of which will be cancelled to reduce the company's registered capital. SUPCON Technology plans to raise the upper limit of its share repurchase price from no more than 68.53 yuan per share to no more than 133.50 yuan per share, while Huaqin Technology carried out its first buyback of 1.057 million A-shares for 79.6009 million yuan. In equity transactions, Lian Tai Environmental intends to sell 100% equity in Hunan Lian Tai and Shantou Lian Tai for a total of 1.611 billion yuan, and Jin Jiang Hotels plans to acquire an additional 10% stake each in Vienna Hotels and Baisuicun Catering for approximately 811 million yuan to achieve full ownership. In addition, Nhwa Pharmaceutical has granted Somnivera exclusive rights to an investigational innovative drug for sleep disorders, with potential milestone payments of up to 507 million US dollars.